Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14592739 | 0.91 | TLR7 (0.63) | TLR7TLR8 | |
| SCHEMBL5354706 | 0.88 | TLR7 (0.61) | TLR7TLR8 | |
| SCHEMBL3864150 | 0.88 | TLR7 (0.52) | TLR7TLR8 | |
| SCHEMBL5748525 | 0.88 | TLR7 (0.64) | TLR7TLR8 | |
| SCHEMBL5750314 | 0.88 | TLR7 (0.64) | TLR7TLR8 | |
| SCHEMBL6097027 | 0.88 | TLR7 (0.74) | TLR7TLR8 | |
| SCHEMBL6053069 | 0.88 | TLR7 (0.58) | TLR7TLR8 | |
| SCHEMBL14592757 | 0.87 | TLR7 (0.73) | TLR7TLR8 | |
| SCHEMBL13613793 | 0.86 | TLR7 (0.58) | TLR7TLR8 | |
| SCHEMBL14592863 | 0.86 | TLR7 (0.72) | TLR7TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110582-B2 | by administering immune response modifier compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-02-07 | — | — | US | disclosed |
| EP-1601365-A2 | PROPHYLACTIC TREATMENT OF UV-INDUCED EPIDERMAL NEOPLASIA | 3M Innovative Properties Company (US) | 2005-12-07 | — | — | EP | disclosed |
| WO-2004078138-A2 | PROPHYLACTIC TREATMENT OF UV-INDUCED EPIDERMAL NEOPLASIA | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-09-16 | — | — | WO | disclosed |
| US-20040175336-A1 | Prophylactic treatment of UV-induced epidermal neoplasia | 3M INNOVATIVE PROPERTIES COMPANY | 2004-09-09 | — | — | US | disclosed |